Company / EPS (Diluted)
Aurinia Pharmaceuticals Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.54
FY2025
5-year range
-$1.40 / -$0.54
FY2021-FY2025
Trend
+28.9%
vs FY2024
Sector context
#73 of 204
Health Care
What the data says
At $-0.54, Aurinia Pharmaceuticals Inc.'s eps (diluted) ranks #73 of 204 in the Health Care sector. EPS (Diluted) has fluctuated over the past 7 years, ranging from $-1.40 in FY2023 to $-0.54 in FY2025.
Based on SEC 10-K filings.
-0.54 in FY2025.
Improved from $-1.40 to $-0.54 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 204 in Health CareTop 36% of 204This company -$0.54 Sector average -$0.98
▼
+44.9% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 28.9% year-over-year.
- Ranks #73 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.54 | +28.9% |
| FY2024 | -$0.76 | +45.7% |
| FY2023 | -$1.40 | -60.9% |
| FY2022 | -$0.87 | +8.4% |
| FY2021 | -$0.95 | -50.8% |
| FY2020 | -$0.63 | +33.7% |
| FY2019 | -$0.95 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026